Shoulder Innovations, Inc. (SI)
NYSE: SI · Real-Time Price · USD
15.20
+0.08 (0.53%)
Dec 5, 2025, 4:00 PM EST - Market closed
Company Description
Shoulder Innovations, Inc. designs, develops, manufactures, and distributes implant replacement systems for shoulder arthroplasty in the United States.
It designs InSet Glenoid technology that aims to reduce mechanical stress at the bone implant interface, improve fixation mechanics, enhance stability, and reduce micromotion.
The company was incorporated in 2009 and is headquartered in Grand Rapids, Michigan.
Shoulder Innovations, Inc.
| Country | United States |
| Founded | 2009 |
| IPO Date | Jul 31, 2025 |
| Industry | Medical - Specialties |
| Sector | Healthcare |
| Employees | 56 |
| CEO | Robert Ball |
Contact Details
Address: 1535 Steele Avenue SW, Suite B Grand Rapids, Michigan 49507 United States | |
| Phone | 616 294 1026 |
| Website | shoulderinnovations.com |
Stock Details
| Ticker Symbol | SI |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $15.00 |
| CIK Code | 0001699350 |
| CUSIP Number | 82837P408 |
| ISIN Number | US82537J1088 |
| Employer ID | 27-0538764 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Robert Ball | Chief Executive Officer |
| Jeffrey Points | Chief Financial Officer |
| Matthew Ahearn | Chief Operating Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 3, 2025 | 8-K | Current Report |
| Nov 14, 2025 | SCHEDULE 13G | Filing |
| Nov 14, 2025 | SCHEDULE 13G | Filing |
| Nov 12, 2025 | SCHEDULE 13G | Filing |
| Nov 12, 2025 | 10-Q | Quarterly Report |
| Nov 12, 2025 | 8-K | Current Report |
| Sep 9, 2025 | 10-Q | Quarterly Report |
| Sep 9, 2025 | 8-K | Current Report |
| Sep 8, 2025 | SCHEDULE 13G | Filing |
| Aug 8, 2025 | SCHEDULE 13G | Filing |